The European Scientific Working group on Influenza (ESWI) is looking forward to organizing the 7th edition of its ESWI Influenza Conferences in Valencia, Spain, on 13 – 16 September 2020. Over the past years, the ESWI Influenza Conferences have grown into the largest European scientific conferences dedicated to influenza. This edition also welcomes abstract submissions on RSV.
In keeping with its excellent scientific reputation, the upcoming seventh edition will give the floor to the most renowned influenza and RSV scientists, public health experts and healthcare professionals.
Update: due to COVID-19, the event will be held online.
This year’s event aims to showcase a suite of sessions focused on novel drugs and approaches, particularly highlighting non-traditional and traditional therapies that provide an innovative means to spearhead the issue. The conference will also place significant emphasis on the much-needed support for innovative approaches such as sessions tackling the funding and support and the regulation that provides guidance towards the goal of ameliorating the continued rise of anti-microbial resistance (AMR).
Update – this event has been postponed.
This two-day international awareness session gives an insight into:
- the European regulatory system for veterinary medicines;
- the role of the European Medicines Agency (EMA) and the European medicines regulatory network;
- specific aspects of the new Veterinary Medicines Regulation.
It will discuss veterinary topics such as antimicrobial resistance, support for innovation and collaboration with academia.
Salmonella and Campylobacter are becoming increasingly resistant to ciprofloxacin, one of the antibiotics of choice for treating infections caused by these bacteria. The conclusion is part of the latest report on antimicrobial resistance in zoonoses released today by the European Centre for Disease Prevention and Control (ECDC) and the European Food Safety Authority (EFSA), which also presents some positive trends in the animal sector.
Today, the European Commission published its 4th progress report on the implementation of the European One Health Action Plan against Antimicrobial Resistance, which was adopted in June 2017. Substantial progress has been made since the last progress report published mid-2019). This includes meetings of the AMR One Health Network and of the Health Security Committee to enhance cooperation and coordination on AMR and One Health visits to Member States to support the implementation of national One Health action plans.